Best Grants for Cancer Nonprofits in Washington

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Eligible 501(c)(3) and nonprofit civic organizations in Washington’s Eastside communities can apply for Overlake Hospital Medical Center’s corporate sponsorships to support community-benefit programs and events, especially around cancer, healthcare access, homelessness, mental health, and substance abuse. Cancer-focused nonprofits in Bellevue, Issaquah, Kirkland, Redmond, Sammamish, and nearby cities may be competitive if they align with Overlake’s community health priorities.

Patients in Washington being treated for Waldenstrom macroglobulinemia can apply for Healthwell Foundation’s grants, offering up to US $8,000 for prescription drug copays and Medicare Part B insurance premiums. U.S. cancer patients who are underinsured, have qualifying income levels, and receive covered treatments may benefit from this support.

Researchers at U.S. academic institutions or eligible nonprofits, including those in Washington, can seek support for high-risk, high-reward translational cancer projects focused on Fanconi anemia. With a mission to end cancer, American Cancer Society and Fanconi Cancer Foundation provide more than US $135,000 for innovative work in detection, prevention, or treatment of FA-related cancers.

With a mission to reduce financial barriers to care, HealthWell Foundation provides Washington cancer and oncology patients with help covering Mantle Cell Lymphoma treatment costs. Underinsured individuals treated in the U.S. with qualifying insurance may receive up to US $8,500 toward prescription drug copays and Medicare Part B premiums for covered MCL therapies.

Individuals in the U.S. being treated for chronic lymphocytic leukemia can apply for Healthwell Foundation’s copay and premium assistance grants, with awards up to US $8,000 for covered medications. Washington cancer nonprofits supporting underinsured CLL patients may help eligible clients access this fund for prescription and Medicare Part B costs.

Individuals in the U.S. being treated for cancer-related behavioral health conditions can receive up to US $2,000 to offset prescription copays, counseling, psychotherapy, and transportation costs. Healthwell Foundation supports underinsured patients whose income and insurance meet its guidelines; Washington cancer nonprofits may share this resource with eligible patients they serve.

Washington cancer and amyloidosis patients with health insurance can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. Individuals being treated for amyloidosis in the U.S. who meet Healthwell Foundation’s medical, insurance, and income guidelines may be eligible for this financial assistance with covered medications.

Elderly professional blues musicians in Washington facing emergency medical or basic living expenses can receive assistance for services like doctor visits, transportation to treatments, utilities, or burial costs. The Pinetop Perkins Foundation provides this U.S.-wide support, which may benefit cancer patients needing help with treatment-related transportation or care costs.

Organizations conducting cancer-related comparative clinical effectiveness research can apply for funding up to Up to US $13,000,000 to improve care and outcomes across the cancer care continuum. Grants from Patient-Centered Outcomes Research Institute help U.S.-recognized private and public sector entities, including those in Washington, partner with communities to address screening barriers, treatment quality, and survivorship follow-up needs.

Cancer research institutions and other eligible organizations in Washington can seek funding for retrospective, patient-centered comparative clinical effectiveness research using existing data sources. The Patient-Centered Outcomes Research Institute supports studies addressing cancer and related health conditions that inform healthcare decision making and improve outcomes, with awards up to US $2,000,000.

Cancer research institutions and translational research centers in Washington conducting human-focused cancer/oncology studies can access funding through the National Institutes of Health. This National Cancer Institute SPORE P50 program offers US $25,000,000 to support state-of-the-art translational research improving prevention, early detection, diagnosis, and treatment of organ-specific or biologically related human cancers, including cross-cutting themes like pediatric cancers or epigenetics.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can apply for tuition and professional development support, including certifications and conferences. Grants from Heart of Illinois Community Foundation help those in Macon, Moultrie, or Piatt County advance cancer-related training, which may benefit Washington cancer nonprofits through better-prepared providers.

Washington cancer clinicians in radiation oncology can access funding through the American Society for Radiation Oncology and the American Cancer Society to build independent research careers. Full-time faculty at U.S. academic institutions or eligible nonprofits with clinical duties may receive about US $135,000 annually for 3–5 years to conduct cancer research while maintaining clinical practice.

Practicing radiation oncologists in the U.S. conducting cancer research can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, with awards of US $729,000 over three to five years. Washington cancer-focused institutions may benefit if they support a clinician scientist pursuing research across the cancer care continuum.

Nonprofit healthcare organizations, medical schools, hospitals, and patient advocacy groups working on cancer and other diseases can seek funding for healthcare-focused programs in Washington. Incyte supports initiatives that provide healthcare information and education for students, providers, patients, and caregivers. Grants, charitable contributions, and sponsorships are available to eligible 501(c)(3) and other tax-exempt organizations.

Incyte Corporation invites organizations to submit membership requests aimed at enhancing healthcare access for patients and advocates. As a biopharmaceutical leader, Incyte supports initiatives that align with its mission to improve patient lives through grants and contributions. Eligible entities include medical schools, associations, non-profits, and advocacy groups. Requests should comply with Incyte's regulatory standards and be submitted at least 60 days prior to the required decision date.

The 2026 Radiation Oncology Institute- Innovation Awards aim to advance cancer treatment by integrating radiation therapy with immunotherapy. Researchers are invited to submit proposals that explore optimal combinations of these modalities to enhance patient outcomes. Funding of up to $100,000 over two years will support projects focused on identifying effective treatment strategies, understanding mechanisms of synergy, and improving access to care. This initiative represents a significant opportunity for innovative research in oncology.

The CDC's initiative focuses on developing clinical decision support (CDS) tools for cancer screening and management, specifically for cervical, breast, and colorectal cancers. The project aims to enhance guideline-concordant screening and improve management processes through rigorous implementation and evaluation within large health systems. By integrating these tools into electronic health records, the initiative seeks to support clinicians in making evidence-based decisions at the point of care, ultimately improving patient outcomes in cancer care.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.